Smoking and AMD—Are E-Cigarettes the Answer?

by Dan Roberts You’ve heard it before: “Tobacco Smoking Is A Major Cause Of Age Related Macular Degeneration”. According to most research, individuals 65 years of age and over double their risk of developing age-related macular degeneration (AMD) if they smoke. Why? Because tobacco smoking: Reduces levels of plasma antioxidant, a substance in the blood [Read More]

Triple Therapy with Zeaxanthin Lessens Burden of Treatment for Wet AMD

As far back as 2007, triple therapy for wet (neovascular) age-related macular degeneration (AMD) was shown to be superior to mono therapy (intraocular injection of a single anti-VEGF drug).* And now, a study described in a recent online publication of the peer-reviewed monthly, International Journal of Retina and Vitreous, found that triple therapy supplemented with [Read More]

A Fish Tale

by Ellen Troyer, MT, MA CEO, Biosyntrx While Biosyntrx supports a limited amount of omega-3 fatty acid EPA and DHA intake from fish or fish oil, we believe it’s important to discuss the growing amount of science that questions excessive fish oil intake. Hypothesis Vs. Outcome An April 14, 2014, meta-analysis-accepted manuscript in the Canadian [Read More]

Effects of AREDS Supplements Up In Smoke

Canadian researchers recently conducted a telephone survey to evaluate patients’ understanding of the importance and adherence to various lifestyle and Age-Related Eye Disease Study (AREDS) supplement recommendations. Tobacco smoking was one of the lifestyle choices looked at. Of the 92 patients contacted, 98% knew about the AREDS formula, with 74% agreeing that high doses of [Read More]